Boston Scientific Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 9.56%

Boston Scientific Corporation Return on Equity (ROE) is 9.56% for the Trailing 12 Months (TTM) ending March 31, 2025, a 2.83% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Boston Scientific Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 9.29%, a 86.91% change year over year.
  • Boston Scientific Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 4.97%, a 8.26% change year over year.
  • Boston Scientific Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 4.59%, a 303.63% change year over year.
  • Boston Scientific Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 1.14%, a -96.89% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share